Zanaflex and Osteoporosis - a phase IV clinical study of FDA data
Osteoporosis is found among people who take Zanaflex, especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Zanaflex and have Osteoporosis. It is created by eHealthMe based on reports of 14,769 people who have side effects when taking Zanaflex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
14,769 people reported to have side effects when taking Zanaflex.
Among them, 146 people (0.99%) have Osteoporosis.
What is Zanaflex?
Zanaflex has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 15,863 Zanaflex users for its effectiveness, alternative drugs and more.
What is Osteoporosis?
Osteoporosis (bones weak and more likely to break) is found to be associated with 2,372 drugs and 1,807 conditions by eHealthMe.
Number of Zanaflex and Osteoporosis reports submitted per year:
Time on Zanaflex when people have Osteoporosis *:
Gender of people who have Osteoporosis when taking Zanaflex*:
Age of people who have Osteoporosis when taking Zanaflex *:
Common drugs people take besides Zanaflex *:
Common side effects people have besides Osteoporosis *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zanaflex and have Osteoporosis?Check whether Osteoporosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hirschmann S, Gibel A, Tsvelikhovsky I, Lisker A, "Late-Onset Psychosis and Risedronate Treatment for Osteoporosis: A Case Report", Clinical schizophrenia & related psychoses, 2013 May .
- Ko KD, Cho BL, "Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis", Journal of the Korean Geriatrics Society, 2012 Dec .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
How severe was Osteoporosis and when was it recovered:
Expand to all the drugs that have ingredients of tizanidine hydrochloride:
Alternative drugs to, pros and cons of Zanaflex:
- Zanaflex (15,863 reports)
Common Zanaflex side effects:
Browse all side effects of Zanaflex:a b c d e f g h i j k l m n o p q r s t u v w x y z
Osteoporosis treatments and more:
- Osteoporosis (254,707 reports)
COVID vaccines that are related to Osteoporosis:
- Osteoporosis in Moderna COVID Vaccine
- Osteoporosis in Pfizer BioNTech Covid Vaccine
- Osteoporosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Osteoporosis:
All the drugs that are associated with Osteoporosis:
- Osteoporosis (2,372 drugs)
Common conditions associated with Osteoporosis:
All the conditions that are associated with Osteoporosis:
- Osteoporosis (1,807 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tizanidine hydrochloride (the active ingredients of Zanaflex) and Zanaflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cylert and Tinnitus - 4 seconds ago
- Colazal and Abilify drug interaction - 5 seconds ago
- Famvir and Cytomegalovirus Test Positive - 6 seconds ago
- Primidone and Renal Failure Chronic - 7 seconds ago
- Duragesic and Catheter Site Cellulitis - 10 seconds ago
- Vectibix and Drug Ineffective - 24 seconds ago
- Doxycycline Hyclate and Papilloedema - 32 seconds ago
- Aredia and Vaginal Bleeding - 40 seconds ago
- Zantac and Vascular Resistance Systemic Decreased - 44 seconds ago
- Letairis and Sinus Tachycardia - 45 seconds ago